Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company new directors buy shares on market

The two directors purchased a combined $74,000+ worth of shares this week.
three empty boardroom seats
Shares in the company were last trading at 55 cents per share

The Hydroponics Company Ltd (ASX:THC) has received a vote of confidence from its two recently appointed board members, who have both recently purchased shares on market.

Lou Cattelan and Gary Radcliff were voted in by shareholders as directors of the board at an extraordinary general meeting (EGM) in March 2018.

Cattelan purchased $51,323 worth of shares at an average price of 58 cents through on-market trades this week.

Similarly, Radcliff purchased $23,369 worth of shares also through on-market trades this week.

READ: The Hydroponics Company recognises value in manufacturing facility

Radcliff is a barrister and is president of the Gold Coast Bar Association.

Cattelan is a pharmaceutical executive with over 30 years experience in technical and operations management in the pharmaceutical and related industries with organisations such as Vitaplex, Soul Pattinson, Wella and Blackmores.

View full THC profile View Profile

The Hydroponics Company Timeline

Related Articles

3d rendering of an antibody
July 24 2018
It is teaming up with Bach BioSciences, a company commercialising the research of William Bachovchin, a professor at Tufts University School of Medicine, Boston
little girl sneezing in a field
May 21 2018
The Phase II study of Allergy Therapeutics’ PQ Grass immunotherapy – an aluminium-free, ultra-short course hay fever treatment – evaluated dose response and safety
pills
July 26 2018
Under former chief executive Peter George and his successor Shaun Chilton, Clinigen has been transformed via a series of well-judged, quickly integrated and cash generative acquisitions

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use